TransCode Therapeutics

Updated: October 09, 2025

CEO - Philippe Calais

Country: USA | Funding: $48.1M (+)

Website: https://www.transcodetherapeutics.com

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

Competitors